TY  - GEN
AU  - Christersson,C
AU  - Oldgren,J
AU  - Wallentin,L
AU  - Siegbahn,A
TI  - Treatment with an oral direct thrombin inhibitor decreases platelet activity but increases markers of inflammation in patients with myocardial infarction
SN  - 1365-2796
PY  - 2011///1003
KW  - Administration, Oral
KW  - Aged
KW  - Aged, 80 and over
KW  - Antithrombins
KW  - administration & dosage
KW  - Aspirin
KW  - Azetidines
KW  - Benzylamines
KW  - Biomarkers
KW  - blood
KW  - Blood Platelets
KW  - drug effects
KW  - C-Reactive Protein
KW  - metabolism
KW  - Comorbidity
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Drug Therapy, Combination
KW  - Female
KW  - Humans
KW  - Inflammation
KW  - Interleukin-10
KW  - Interleukin-18
KW  - Male
KW  - Middle Aged
KW  - Myocardial Infarction
KW  - P-Selectin
KW  - Platelet Activation
KW  - Risk Factors
KW  - Thromboplastin
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2796.2011.02354.x
ER  -